Get the latest tech news
Google plans to release new ‘open’ AI models for drug discovery
During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models for drug discovery called
During a health-focused event in New York on Tuesday, Google announced that it’s developing a collection of “open” AI models for drug discovery called TxGemma. Countless companies, including Google spin-out Isomorphic Labs, have promised that AI could one day revolutionize drug discovery by dramatically accelerating the earliest R&D steps. In January, Isomorphic, which has partnerships with pharma giants Eli Lilly and Novartis, said that it expects testing on its AI-designed drugs to begin sometime this year.
Or read this on TechCrunch